| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11684-018-0617-0 |
| P698 | PubMed publication ID | 29524068 |
| P2093 | author name string | Jieshou Li | |
| Chenyang Wang | |||
| Qiurong Li | |||
| P2860 | cites work | Diversity of the human intestinal microbial flora | Q24544241 |
| Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation | Q24626051 | ||
| Structure, function and diversity of the healthy human microbiome | Q24626370 | ||
| Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation | Q26771287 | ||
| The role of gut microbiota in immune homeostasis and autoimmunity | Q26860722 | ||
| Fish oil enhances recovery of intestinal microbiota and epithelial integrity in chronic rejection of intestinal transplant | Q27337413 | ||
| Microbial ecology: human gut microbes associated with obesity | Q27861004 | ||
| Duodenal infusion of donor feces for recurrent Clostridium difficile | Q28283517 | ||
| Intestinal microbial variation may predict early acute rejection after liver transplantation in rats | Q28654475 | ||
| Evolution of mammals and their gut microbes | Q28755326 | ||
| A metagenome-wide association study of gut microbiota in type 2 diabetes | Q29547726 | ||
| Gut microbiota from twins discordant for obesity modulate metabolism in mice | Q29614796 | ||
| Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 | Q29615053 | ||
| Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome | Q29616853 | ||
| Richness of human gut microbiome correlates with metabolic markers | Q29617365 | ||
| The microbiome in inflammatory bowel disease: current status and the future ahead | Q33664898 | ||
| Role of the microbiota in immunity and inflammation | Q33752553 | ||
| Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis | Q33914907 | ||
| Reciprocal interactions of the intestinal microbiota and immune system. | Q34033579 | ||
| The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. | Q34047880 | ||
| Complete suppression of the gut microbiome prevents acute graft-versus-host disease following allogeneic bone marrow transplantation | Q34121789 | ||
| Intestinal transplantation before and after the introduction of sirolimus. | Q34131258 | ||
| Intestinal transplantation: current status and future directions. | Q34186211 | ||
| Deciphering the tête-à-tête between the microbiota and the immune system | Q34311731 | ||
| Reciprocal interaction between intestinal microbiota and mucosal lymphocyte in cynomolgus monkeys after alemtuzumab treatment | Q34596752 | ||
| Sequencing the human microbiome in health and disease. | Q34940785 | ||
| Human gut microbiome adopts an alternative state following small bowel transplantation | Q35006562 | ||
| Human microbiota characterization in the course of renal transplantation. | Q35076833 | ||
| Fecal microbiota transplantation for refractory Clostridium difficile colitis in solid organ transplant recipients | Q35085463 | ||
| Pathogenesis of chronic allograft rejection | Q35094243 | ||
| Successful treatment of severe sepsis and diarrhea after vagotomy utilizing fecal microbiota transplantation: a case report | Q35136477 | ||
| Alterations of the human gut microbiome in liver cirrhosis | Q35216354 | ||
| Lymphocyte depletion after alemtuzumab induction disrupts intestinal fungal microbiota in cynomolgus monkeys | Q35227850 | ||
| Microbiota—implications for immunity and transplantation | Q35627459 | ||
| Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome. | Q35713301 | ||
| An analysis of the long-term complications of intestine transplant recipients | Q36016244 | ||
| Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation | Q36130498 | ||
| Treatment of intestinal failure: intestinal transplantation. | Q36927965 | ||
| Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice | Q37191056 | ||
| Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. | Q37376599 | ||
| Small intestine and microbiota | Q37811852 | ||
| The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease. | Q39035437 | ||
| Characterization of the ileal microbiota in rejecting and nonrejecting recipients of small bowel transplants | Q39677699 | ||
| Calprotectin: a novel noninvasive marker for intestinal allograft monitoring. | Q40187909 | ||
| Toll-like receptor 4 contributes to small intestine allograft rejection | Q42688213 | ||
| Exfoliative rejection after intestinal transplantation in children. | Q44447013 | ||
| The gut microbiota and obesity: from correlation to causality | Q44559588 | ||
| Isolated intestinal transplantation: proof of clinical efficacy | Q44584359 | ||
| Abdominal cluster transplantation and management of perioperative hemodynamic changes | Q44802464 | ||
| Long-term survival, nutritional autonomy, and quality of life after intestinal and multivisceral transplantation | Q44832371 | ||
| The price of donation after cardiac death in liver transplantation: a prospective cost-effectiveness study | Q45350883 | ||
| Therapeutic modulation and reestablishment of the intestinal microbiota with fecal microbiota transplantation resolves sepsis and diarrhea in a patient | Q46817617 | ||
| Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. | Q51169431 | ||
| The reduction of allograft arteriosclerosis in intestinal transplant is associated with sphingosine kinase 1/sphingosine-1-phosphate signaling after fish oil treatment. | Q54519876 | ||
| Outcome, Incidence, and Timing of Infectious Complications in Small Bowel and Multivisceral Organ Transplantation Patients | Q58798142 | ||
| A rat small bowel transplant model of chronic rejection: histopathologic characteristics | Q73068828 | ||
| The value of plasma citrulline to predict mucosal injury in intestinal allografts | Q80211863 | ||
| Inhibition of sonic hedgehog signaling reduces chronic rejection and prolongs allograft survival in a rat orthotopic small bowel transplantation model | Q80370926 | ||
| Intestinal transplantation | Q84510732 | ||
| Influence of alemtuzumab on the intestinal Paneth cells and microflora in macaques | Q84530839 | ||
| Microbial cocktails join fecal transplants in IBD treatment trials | Q85852381 | ||
| P577 | publication date | 2018-03-09 | |
| P1433 | published in | Frontiers of medicine | Q26867043 |
| P1476 | title | Gut microbiota and its implications in small bowel transplantation. |
Search more.